In a report released today, Jeff Van Rhee from Craig-Hallum maintained a Buy rating on Cellebrite DI (CLBT – Research Report). The company’s ...

TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors ...

Needham & Company LLC reiterated their buy rating on shares of Cellebrite DI (NASDAQ:CLBT – Free Report) in a report released on Thursday morning,Benzinga reports. They currently have a $28.00 target ...

It involves the sale by Cellebrite of an attack chain that could defeat the lock screen of fully patched Android devices. The exploits were used against a Serbian student who had been critical of ...

The latest price target for Cellebrite DI (NASDAQ:CLBT) was reported by Needham on March 27, 2025. The analyst firm set a price target for $28.00 expecting CLBT to rise to within 12 months (a ...

Cellebrite DI Ltd TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and ...

Cellebrite Guardian, Cellebrite's SaaS-based evidence management solution, now includes Generative Artificial Intelligence (GenAI) capabilities. By incorporating GenAI into Guardian, public safety ...

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 18, 2025 (GLOBE NEWSWIRE) -- Cellebrite (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today ...